Results released Friday show itepekimab succeeded in one Phase 3 trial but failed in a second, sinking shares of both partner ...

Remember, COPD treatment is a long-term journey with many facets, and each case is different. For example, you might be great at keeping up with your medications and doctor appointments but not so ...

Most people with COPD in the United States are at least 40 years old and have a history of smoking, making smoking cessation a critical part of treatment along with medications, oxygen therapy ...

Eucalyptus oil was first used by Aboriginal Australians, who crushed the leaves for their antiseptic properties or steamed ...

GSK has gained approval from the US Food and Drug Administration (FDA) for its monoclonal antibody, Nucala (mepolizumab), as ...

A robust treatment plan for COPD includes a combination of prescription medication, pulmonary therapies, and healthy lifestyle changes to help relieve symptoms and slow disease progression.

M. Bradley Drummond, MD, MHS, professor of medicine, University of North Carolina at Chapel Hill, shares promising results of ensifentrine in helping patients with insufficient chronic obstructive ...

The FDA granted approval to mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

When you are diagnosed with COPD, it is important to remember that you are not alone. A healthcare team, which may include a ...

Even though there's no cure for chronic obstructive pulmonary disease (COPD), there are many treatments that make you feel better, stay active, live longer, and just breathe easier. When you have ...

Fact checked by Jennifer Klump The symptoms of COPD aren’t always obvious. Subtle signs like finding it harder to keep up with friends on a walk or unconsciously cutting down on physical activity can ...

AERIFY-1 trial met the primary endpoint of a statistically significant reduction in moderate or severe exacerbations in former smokers rega ...